GSK expands cost cutting drive

February 9, 2009
Sales and Marketing GSK, restructure

GlaxoSmithKline has expanded its restructuring plans and will make widespread job cuts in a bid to cut costs throughout its …

India’s Piramal at centre of buy-out speculation

February 9, 2009
Sales and Marketing MA, Piramal

Indian pharmaceutical company Piramal has denied that it ready to sell up to one of the global giants of the …

Schering-Plough invests in Scotland drug discovery centre

February 6, 2009
Research and Development Merck, Scotland

Schering-Plough is to invest around $30 million in its early drug discovery work in Scotland. The company is investing a …

Job losses mounting at smaller drugmakers

February 5, 2009
Sales and Marketing restructure

Another week, and another swathe of job losses across the pharmaceutical sector, with sales and back office staff once again …

What are pharma’s core competencies?

February 5, 2009
Research and Development, Sales and Marketing pharma, strategy

Pharma has always been a highly profitable industry, and has historically been among the best performing industrial sectors in terms …

UK pharma to consider ban on doctor gifts

February 5, 2009
Medical Communications ABPI, Code of Practice, ethics

All gifts from pharma companies to doctors and to medical students – should be banned, according to a new report …

Mixed reaction for national dementia strategy

February 4, 2009
NHS, hc

The government's national dementia strategy, announced this week, has received a mixed reception from patient groups and the media. The …

NICE approves Sutent but rejects rivals

February 4, 2009
Sales and Marketing NICE, par

NICE has approved Pfizer's Sutent but rejected three other treatments for kidney cancer. The decision is one of the first …

How ‘in line’ communications won it for Obama

February 3, 2009
Medical Communications digi

It is undeniable that we live in an 'online' era: digital media and technology have infiltrated almost every aspect of …

The Brand MOT

February 3, 2009
Sales and Marketing branding, marketing

To have a car on the road once it's more than three years old requires an MOT – an annual …

The Pharmafocus Interview: David Gillen

February 3, 2009
Research and Development Pfizer, UK, medicines access

David Gillen says he is a born optimist. But Pfizer UK’s medical director says this positive outlook doesn’t blind him …

PM Society ad awards – results

February 3, 2009
Medical Communications PM Soc, awards

The Pharmaceutical Marketing Society annual advertising awards on Friday were enjoyed in their traditional glittering style, and celebrated the industry's …

Chinese contract manufacturers to benefit from downturn

February 2, 2009
Manufacturing and Production CMO, China

China's contract manufacturing organisation market was valued at more than $70 billion in 2007, with pharmaceuticals comfortably the largest contributor, …

Evidence HRT could reduce bowel cancer risk

February 2, 2009
Research and Development, Sales and Marketing HRT

A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …

The Pfizer-Wyeth merger

February 2, 2009
Research and Development, Sales and Marketing Pfizer, Wyeth, merger, sales

Before the merger, Pfizer faced a significant contraction in sales. Datamonitor's analysis suggests that the company's sales were declining at …

AstraZeneca to cut more jobs as sales stagnate

January 30, 2009
Sales and Marketing AZ, restructure

AstraZeneca's revenues will see virtually no growth in 2009, and the company has extended its cost cutting programme. Chief executive …

Pharma additives ‘risk to premature infants’

January 30, 2009
Manufacturing and Production additives, excipients

Difficulties in dosing medicines for premature babies mean some may be exposed to high levels of pharmaceutical excipients which, despite …

Crucell linked with new takeover suitors

January 29, 2009
Sales and Marketing Crucell, MA

Dutch vaccines firm Crucell could be snapped up by other pharmaceutical companies after Wyeth pulled out of negotiations to buy …

Independent study into NICE’s methods

January 29, 2009
Sales and Marketing NICE, hc

NICE has asked an eminent academic and NHS reformer to conduct an independent study of its approach to appraising new …

RoActemra approved in Europe

January 29, 2009
Sales and Marketing RoActemra, Roche

The European Commission has approved Roche's RoActemra as a treatment for rheumatoid arthritis. Schering-Plough's Remicade, Wyeth's Enbrel and Abbott's Humira …

The Gateway to Local Adoption Series

Latest content